Related Experiment Video

Updated: Feb 15, 2026

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

4.0K

Chemically Defined Antibody- and Small Molecule-Drug Conjugates for in Vivo Tumor Targeting Applications: A

Samuele Cazzamalli1, Alberto Dal Corso1, Fontaine Widmayer1

  • 1Department of Chemistry and Applied Biosciences, Swiss Federal Institute of Technology (ETH Zürich) , Vladimir-Prelog-Weg 4, CH-8093 Zurich, Switzerland.

Journal of the American Chemical Society
|January 18, 2018
PubMed

Insights

This study compares antibody-drug conjugates and small molecule-drug conjugates for cancer therapy. Both drug types target carbonic anhydrase IX, a marker for tumor hypoxia and renal cell carcinoma.

Area of Science:

  • Oncology
  • Pharmacology
  • Biochemistry

Background:

  • Carbonic anhydrase IX (CA IX) is a validated biomarker for tumor hypoxia.
  • CA IX is highly expressed in clear cell renal cell carcinoma (ccRCC).
  • Targeted therapies are crucial for effective cancer treatment.

Purpose of the Study:

  • To directly compare the efficacy of an antibody-drug conjugate (ADC) and a small molecule-drug conjugate (SMDC).
  • To evaluate these conjugates targeting carbonic anhydrase IX (CA IX).
  • To assess their potential as cancer therapeutics, particularly for renal cell carcinoma.

Main Methods:

  • Development of chemically defined ADC and SMDC targeting CA IX.
  • In vitro and in vivo comparative studies.
  • Assessment of binding affinity and therapeutic efficacy.

Main Results:

  • Both ADC and SMDC demonstrated high-affinity binding to CA IX.
  • Comparative data on the therapeutic effectiveness of ADC versus SMDC was generated.
  • The study provides a direct evaluation of these two conjugate types.

Conclusions:

  • Antibody-drug conjugates and small molecule-drug conjugates represent viable therapeutic strategies targeting CA IX.
  • This comparative evaluation informs the development of novel targeted cancer therapies.
  • Further research is warranted to optimize these conjugates for clinical application in renal cell carcinoma and other CA IX-expressing tumors.

More Related Videos

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

6.0K

Related Concept Videos

Conjugated Proteins02:50

Conjugated Proteins

Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
29.2K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
619
Molecules and Compounds02:38

Molecules and Compounds

Atoms and Molecules
69.8K
Chemical Equations03:10

Chemical Equations

Chemical equations represent the identities and relative quantities of substances involved in a chemical reaction. The substances undergoing reaction are called reactants, and their formulas are placed on the left side of the equation. The substances generated by the reaction are called products, and their formulas are placed on the right side of the equation. Plus signs (+) separate individual reactant and product formulas, and an arrow (→) separates the reactant and product (left and right)...
82.3K
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs01:21

Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs

A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
792
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.6K